mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.009 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.01 |